2020 | 4-1BB co-stimulation further enhances anti-PD-1-mediated reinvigoration of exhausted CD39 + CD8 T cells from primary and metastatic sites of epithelial ovarian cancers
| JOURNAL FOR IMMUNOTHERAPY OF CANCER |
2020 | 4-1BB Delineates Distinct Activation Status of Exhausted Tumor-Infiltrating CD8+ T Cells in Hepatocellular Carcinoma | HEPATOLOGY |
2015 | A Comparison of Adenosquamous Carcinoma and Adenocarcinoma of the Cervix after Radical Hysterectomy | GYNECOLOGIC AND OBSTETRIC INVESTIGATION |
2017 | A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy
| BMC CANCER |
2017 | A novel clinicopathological analysis of early stage ovarian Sertoli-Leydig cell tumors at a single institution
| Obstetrics & Gynecology Science |
2022 | A Phase 2 study of prexasertib (LY2606368) in platinum resistant or refractory recurrent ovarian cancer
| GYNECOLOGIC ONCOLOGY |
2019 | A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
2022 | A Phase II Trial to Evaluate the Efficacy of Bortezomib and Liposomal Doxorubicin in Patients With BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer (KGOG 3044/EBLIN)
| IN VIVO |
2021 | A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
2022 | A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
2020 | A Single-Center, Retrospective Study of Bevacizumab-Containing Neoadjuvant Chemotherapy followed by Interval Debulking Surgery for Ovarian Cancer
| YONSEI MEDICAL JOURNAL |
2022 | Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response | CLINICAL CANCER RESEARCH |
2018 | Aberrant uterine leiomyomas with extrauterine manifestation: intravenous leiomyomatosis and benign metastasizing leiomyomas.
| Obstetrics & Gynecology Science |
2022 | Added value of sentinel lymph node biopsy in patients with negative lymph node on triple pre-operative images | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2019 | Adenosine triphosphate-based chemotherapy response assay predicts long-term survival of primary epithelial ovarian cancer | International Journal of Gynecological Cancer |
2016 | An Alternative Triage Strategy Based on Preoperative MRI for Avoiding Trimodality Therapy in Stage IB Cervical Cancer.
| CANCER RESEARCH AND TREATMENT |
2022 | An open label, single arm, multicenter trial of durvalumab and BVAC-C, in patients with HPV 16 or 18 positive recurrent cervical cancer
| INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2019 | An umbrella study of biomarker-driven targeted therapy in patients with platinum-resistant recurrent ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG 3045), AMBITION | JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
2023 | Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
2022 | ARL6IP5 reduces cisplatin-resistance by suppressing DNA repair and promoting apoptosis pathways in ovarian carcinoma
| CELL DEATH & DISEASE |
2019 | Asian Society of Gynecologic Oncology International Workshop 2018
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
2021 | Association between PD-L1 expression and 18 F-FDG uptake in ovarian cancer | ANNALS OF NUCLEAR MEDICINE |
2022 | Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
2023 | BNT162b2 접종과 면역관문억제제 치료 이후 발생한 이상 반응 1예
| Korean Journal of Medicine |
2017 | BRCA1 and BRCA2 mutation predictions using the BRCAPRO and Myriad models in Korean ovarian cancer patients | GYNECOLOGIC ONCOLOGY |
2018 | Can simple trachelectomy or conization show comparable survival rate compared with radical trachelectomy in IA1 cervical cancer patients with lymphovascular space invasion who wish to save fertility? A systematic review and guideline recommendation
| PLOS ONE |
2021 | Cancer Patient Tissueoid with Self-Homing Nano-Targeting of Metabolic Inhibitor
| ADVANCED SCIENCE |
2023 | CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion Therapy | CLINICAL CANCER RESEARCH |
2018 | Changes in ovarian cancer survival during the 20 years before the era of targeted therapy.
| BMC CANCER |
2019 | Comparative Effectiveness of Abdominal versus Laparoscopic Radical Hysterectomy for Cervical Cancer in the Postdissemination Era
| CANCER RESEARCH AND TREATMENT |
2023 | Comparing surgical outcomes of da Vinci SP and da Vinci Xi for endometrial cancer surgical staging in a propensity score-matched study
| SCIENTIFIC REPORTS |
2020 | Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
2018 | Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models
| CANCER RESEARCH AND TREATMENT |
2017 | Comparison of Clinical Outcomes of BRCA1/2 Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer Patients
| CANCER RESEARCH AND TREATMENT |
2023 | Comparison of oncological outcomes between sentinel lymph node biopsy and complete lymphadenectomy for endometrial cancer | JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH |
2020 | Comparison of outcomes between the one-step and two-step sentinel lymph node mapping techniques in endometrial cancer | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2021 | Comparison of Serum Anti-Mullerian Hormone-Level Changes in Single-Port Laparoscopic Endometriotic and Non-Endometriotic Ovarian Cyst Enucleations
| Journal of Menopausal Medicine |
2021 | Comparison of single-port laparoscopy and laparotomy in early ovarian cancer surgical staging
| Obstetrics & Gynecology Science |
2023 | Comparison of Single-Port Laparoscopy with Other Surgical Approaches in Endometrial Cancer Surgical Staging: Propensity-Score-Matched Analysis
| CANCERS |
2023 | Comprehensive genomic and immunohistochemical profiles and outcomes of immunotherapy in patients with recurrent or advanced cervical cancer
| FRONTIERS IN ONCOLOGY |
2022 | Comprehensive profiling of cervix cancer patients using tumor next-generation sequencing (NGS) and immunohistochemistry (IHC) | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2020 | Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy | EUROPEAN JOURNAL OF CANCER |
2015 | Controversies in the management of endometrial cancer: a survey of the Korean Gynecologic Oncology Group
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
2015 | Cost-effectiveness of para-aortic lymphadenectomy before chemoradiotherapy in locally advanced cervical cancer
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
2021 | CT-Based Fagotti Scoring System for Non-Invasive Prediction of Cytoreduction Surgery Outcome in Patients with Advanced Ovarian Cancer
| KOREAN JOURNAL OF RADIOLOGY |
2017 | Delayed hemorrhage effect of local anesthesia with epinephrine in the loop electrosurgical excisional procedure
| Obstetrics & Gynecology Science |
2016 | Detecting Asymptomatic Recurrence in Early-Stage Endometrial Cancer: The Value of Vaginal Cytology, Imaging Studies, and CA-125 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2018 | Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-Gene Panels: Beyond BRCA1/2
| CANCER RESEARCH AND TREATMENT |
2018 | Diagnostic Value of 18F-FDG PET/CT and MRI in the Preoperative Evaluation of Uterine Carcinosarcoma | NUCLEAR MEDICINE AND MOLECULAR IMAGING |
2017 | Difference in Practice Patterns in the Management of Endometrial Cancer: A Survey of the Members of 4 East Asian Gynecologic Oncology Groups | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2018 | Distinct Clinical Courses of Epithelial Ovarian Cancer with Mutations in BRCA1 5' and 3' Exons | Anticancer Research |
2023 | Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial | LANCET ONCOLOGY |
2022 | Durvalumab, in combination with and following chemoradiotherapy, in locally advanced cervical cancer: results from the phase 3 international, randomized, double-blind, placebo-controlled calla trial | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | Dynamic changes of peripheral regulatory t cells during parp inhibitor maintenance therapy in patients with ovarian cancer | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
2022 | Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
| CANCERS |
2017 | Dysregulated expression of homeobox family genes may influence survival outcomes of patients with epithelial ovarian cancer: analysis of data from The Cancer Genome Atlas
| ONCOTARGET |
2020 | Early Assessment of Response to Neoadjuvant Chemotherapy with 18F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer
| CANCER RESEARCH AND TREATMENT |
2020 | Effect of bupivacaine versus lidocaine local anesthesia on postoperative pain reduction in single-port access laparoscopic adnexal surgery using propensity score matching
| Obstetrics & Gynecology Science |
2020 | Effectiveness of adjuvant treatment for morcellated, International Federation of Gynecology and Obstetrics stage I uterine leiomyosarcoma: A Korean multicenter study | JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH |
2021 | Effects of Korean Red Ginseng ( Panax ginseng C.A. Meyer) on Menopausal Symptoms in Premenopausal Women After Gynecologic Cancer Surgery: A Double-Blind, Randomized Controlled Trial | JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE |